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DETECTION ON COMMON DELETIONAL ALPHA THALASSAEMIA IN 
PREGNANT WOMEN BY POLYMERASE CHAIN REACTION 
TECHNIQUES 
 
ABSTRACT 
Thalassaemia is the most common inherited disorder worldwide and 
represent as a major health problem in many areas and approximately 4.5%-
6% of Malaysians are carrier of this genetic disorder. There are two type of 
thalassaemia which α and β thalassemia. α-thalassaemia either the deletion 
of a single or double α-globin gene deletion that is located at position 16p3.3 
is the one of the most common genetic disorder in the world. In Malaysia, the 
incidence is 4.5%. The aims of this study were to identify and characterised 
the common deletional type cases of α-thalassaemia in Malay pregnant 
women at HUSM by molecular method. A total of 200 Malay pregnant 
women who attended for an antenatal check-up at Hospital Universiti Sains 
Malaysia were screened for α-thalassaemia. DNA was extracted from 200 
pregnant women blood using commercial DNA extraction kit prior to PCR 
amplification. Of these, 16 were excluded as they were diagnosed as β-
thalassaemia/Hb E trait. Out of 184 genomic DNA, 17 (9.2%) were 
possessed α-thalassaemia deletion. The genotype could be identified to -
α3.7/αα in 15 (8.1%) and --SEA/αα in 2(1.1%). While -α4.2 kb deletion and --THAI 
deletion was not detected in our subjects. Thus, the most common deletion in 
the Malays pregnant women were -α3.7 followed by --SEA.  The molecular 
method has been established to detect these carriers. The presence of two 
xv 
 
gene deletion evidenced by --SEA. showed the importance to screen α-
thalassaemia among Malay pregnant women and subsequent screening 
patients' spouse to exclude hydrops fetalis. Detection of --SEA α-thalassaemia 
by PCR techniques is convenient, and suitable to be used as a confirmatory 
test. 
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PENGESANAN PEMOTONGAN UMUM TALASEMIA ALFA DALAM 
WANITA MENGANDUNG YANG DITENTUKAN OLEH TEKNIK 
TINDAKBALAS BERANTAI POLIMERASE (PCR) 
 
ABSTRAK 
 
Talasemia adalah penyakit warisan yang paling umum di seluruh dunia dan 
merupakan masalah kesihatan utama  dan kira-kira 4.5% -6 % daripada 
rakyat Malaysia adalah pembawa penyakit genetik ini. Talasemia terbahagi 
kepada dua jenis iaitu α-talasemia dan β-talasemia. α-talasemia sama ada 
pemotongan pada gen α-globin tunggal atau berganda yang terletak di 
kedudukan kromosom 16p3.3 adalah merupakan  salah satu penyakit 
genetik yang paling umum di dunia. Kira-kira 4.5% pengidap penyakit α- 
talasemia di Malaysia. Tujuan kajian ini adalah untuk mengenal pasti jenis 
pemotongan α-talasemia yang umum di kalangan wanita hamil Melayu di 
HUSM menggunakan teknik molekul. Seramai 200 orang wanita Melayu 
hamil yang hadir untuk pemeriksaan sebelum bersalin di Hospital Universiti 
Sains Malaysia telah disaring untuk α-talasemia. DNA telah diektrak 
daripada darah 200 orang wanita Melayu hamil tersebut dengan 
menggunakan kit ekstrak darah komersial sebelum diamplifikasikan melalui 
kaedah tindakbalas berantai polimerase (PCR). Daripada jumlah ini, 
sebanyak 16 orang telah dikecualikan kerana mereka disahkan mengidap β-
talasemia atau Hb E. Daripada 184 DNA genomik, 17 (9.2%) telah 
mempunyai pemotongan α-talasemia. Genotip yang dikenalpasti adalah -
xvii 
 
α3.7/αα seramai 15 orang (8.1 %) dan --SEA/αα seramai 2 orang (1.1%). 
Walaubagaimanapun, pemotongan jenis -α4.2 dan --THAI tidak berjaya 
dikesan.  Oleh itu, jenis pemotongan yang paling umum di kalangan wanita 
Melayu hamil adalah -α3.7 diikuti oleh --SEA. Teknik PCR telah berjaya di 
tubuhkan. Jenis pemotongan dua gen atau pemotongan berganda di sahkan 
dengan kehadiran --SEA  amat penting dikenalpasti terutama dalam wanita 
Melayu yang hamil supaya saringan penyakit α-talasemia dapat dijalankan 
keatas suami pesakit tersebut bagi menghalang kejadian hidrop fetalis. 
Penemuan --SEA menggunakan teknik PCR merupakan teknik yang sesuai 
digunakan dalam pengesahan penyakit α-talasemia. 
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 CHAPTER 1 
 
 
INTRODUCTION 
 
 
1.1 Statement and Significance of the problem 
 
Thalassaemia is a major health problem worldwide and approximately 1 in 14 
is carrier (Xiofeng, G. and Yitao, Z., 2002). It is common in people of Asian 
descent and has emerged as public health problem in Malaysia. In Kelantan, 
the Northeast region of Malaysia, which is situated at the border of Thailand, 
thalassaemia is prevalent. It is expected the disease phenotype and 
genotype would resemble that of Thailand. In Thailand, with the total of 60 
million populations, approximately one percent affected individuals and more 
than 20 million were thalassaemia carriers (Greenberg et al., 2001). 
 
A preliminary study done among blood donor in USM showed that the 
prevalence of thalassaemia was 15% with Hb E/α is the commonest followed 
by Hb E trait (Rosline, H et al., 2006). In another local data, the commonest 
thalassaemia among transfusion dependent patients is Hb E/ß. These data 
shows an extreme diversity in clinical presentation of thalassaemia patients 
spanning from asymptomatic thalassaemia trait to transfusion dependent 
(Rozitah, R et al., 2008). Population screening for thalassaemia carrier is first 
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needed to understand the genotype basis of this complex interaction which 
gives rise to the major socioeconomic problem to the country. 
 
The α-thalassaemia is mainly caused by a large deletion of the α-globin gene 
and occurs when one or more of the four alphas (α) chain genes fail to 
function. α-thalassaemia is the one of the most common inherited disorder of 
haemoglobin synthesis and commonly found in Southeast Asian, 
Mediterranean and Middle Eastern population (Guvenc, B et al, 2010). 
Clinical phenotype of the carriers varies according to the number of affected 
gene.  
 
α-thalassaemia can be classified into two types which were α-thalassaemia-1 
(α0-thalassaemia), the deletion of both α1- and α2- globin genes and this 
type have mild microcytic, hypochromic anaemia with normal haemoglobin 
A2 levels and α-thalassaemia-2 (α+-thalassaemia) where only one α-globin 
gene deletion has occurred, present with no detectable red blood cell 
abnormalities or globin chain imbalance (Weatherall, D.J., and Clegg, J.B., 
2001).   
 
The prevalence of α-thalassaemia-1 is around 3-4% and for α-thalassaemia-
2 is 20-30% (Sanguansermsri, T., et al, 1999) and it resulted from deletion 
and non-deletional mutations. The commonest form is α-gene deletion. The 
five common type of α-gene deletion in South East Asian region are --SEA,     
--THAI,--FIL,-α3.7 and -α4.2 (D.R. Higgs, 2013). The worst outcome of                
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α-thalassaemia is Hb Bart’s hydrops foetalis. However, Hb H disease due to 
three deletions of genes is associated with increased morbidity. 
 
Since thalassaemia is now a public health problem in Malaysia, there is need 
to raise public awareness in the community. This study focused on detection 
of carrier of the commonest α-gene deletion which --SEA, --THAI, -α3.7 and -α4.2 
among pregnant women in this population. --SEA deletion is severe form of α-
thalassaemia determinant in Southeast Asian country including Malaysia.  
 
The control of thalassaemia remains a major challenge. The conventional 
approach to screen and diagnose haemoglobinopathies requires a 
combination of test. These methods, including erythrocyte indices and 
morphology, Hb electrophoresis, quantitation of Hb A2, Hb E, and Hb F, and 
detection of erythrocytes containing Hb H inclusion bodies (Sanchasuriya, K 
et al., 2003). To screen for thalassaemia carriers in the whole population, is 
costly however it has clinical importance.  
 
Among our population, pregnant women is the group of choice for the 
screening strategy in order to characterised their carrier state and to provide  
sufficient information beside to estimate the risk that their children would 
have severe disease such as α-globin mutation and also β-globin mutation. 
All the strategies are aiming at reducing the birth of dependent form of 
thalassaemia that can increase public health problem in Malaysia. 
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In order to succeed in prevention and control of thalassaemia, we have 
develop a diagnostic tool that is polymerase chain reaction (PCR) techniques 
to detect the most common form of α-thalassemia such as --SEA deletion,       
--THAI deletion, -α3.7 rightward deletion and -α4.2 leftward deletion in Malay 
population. This method is simple, reliable and suitable for population 
screening and routine diagnosis. Based on this information, genetic 
counselling can be practiced later. 
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1.2  Literature Review 
 
1.2.1 Haemoglobin Structure and Function 
 
Haemoglobin is an iron-rich protein in red blood cells. Haemoglobin is 
essential for the existence of human life and also the remarkable protein that 
enables red blood cells to carry oxygen and carbon dioxide. Haemoglobin 
tetramers are comprised of the four subunits, two α-globin chains and two β-
globin chains and each having one polypeptide chain and one haem group 
(Alain, J., 2006)( Figure 1.1). All of which take the form of α helices.  
 
In thalassaemia disorders, the haem part of haemoglobin is entirely normal. 
The defect lies exclusively with the globin part of haemoglobin. This defect 
results in the underproduction of globin and, hence, the underproduction of 
haemoglobin. 
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Figure 1.1 Structure of the haemoglobin molecule with four globin chain and 
a haem group within each.  
(Adapted from www.themedicalbiochemistrypage.org/protein-structure.php). 
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1.2.2 Haemoglobin Synthesis during Development 
 
Normal adult have major haemoglobin called Hb A comprising about 97% of 
the total and a minor component, Hb A2 that accounts 2-3% of total 
haemoglobin in foetus. Foetal haemoglobin, Hb F (α2γ2) represents 90-95% 
of haemoglobin by 34-36 week gestation. After 34 week gestation, Hb A 
production increase significantly as falls of Hb F productions. Small amount 
of Hb A2 is produced from birth and usually reached adult levels by 6 months 
of age, although it can rise further for the first 1-2 years of life (Ryan K, et al, 
2010).  
 
During the embryonic stages of foetal development, there are three 
embryonic haemoglobin, haemoglobins Gower 1, Gower 2 and 
haemoglobins Portland (Table 1.1). The production of this different 
haemoglobin is a reflection of a series of physiological adaptations to 
differing O2 requirement at various stages of development (Ryan K, et al, 
2010). The normal pattern of haemoglobin synthesis is summarised in Figure 
1.2  
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Table 1.1: Haemoglobin gene expression 
 
Developmental Period Haemoglobin Species Globin Chain 
Embryonic Gower 1 ζ2 ε2 
Portland ζ2 γG or A 
Gower 2 α2 ε2 
Foetal Haemoglobin F α2 γ2G or A 
Adult Haemoglobin A α2 β2 
Haemoglobin A2 α2 δ2 
Haemoglobin F α2 γ2G or A 
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Figure 1.2: The normal pattern of haemoglobin synthesis. (Adapted from 
Ryan K, et al, 2010). 
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1.2.3 Thalassaemia 
 
The name of thalassaemia is derived from a combination of two Greek words 
which are thalassa and anaemia. Thalassa means the Mediterranean Sea 
and anaemia in Greek means weak (an) and blood (haima). Thalassaemia is 
a group of genetic, inherited disorders of the blood.  More specifically, it is a 
disorder of the haemoglobin molecule inside the red blood cells.  It is an 
inherited genetic disease where it is passes from parents to children through 
the genes. It is not infectious and cannot be passed from one individual to 
the other by personal or any other contact. Thalassaemia occurs widely 
throughout the Mediterranean region, Africa, Indian, Middle East and 
Southeast Asia population. The most important disorders are α-thalassaemia 
and β-thalassaemia (Rachmilewitz, E. A., and Giardina, P.J., 2011). 
 
α-thalassaemia is caused by the deletion or mutation of α-globin gene and 
characterised by reduce or absence of the α-globin chain ( Rappaport V.J., et 
al, 2004). In contrast, β-thalassaemia is due to a point mutation in one of the 
β-globin gene and leading to decreased or absence of β-globin chain of the 
haemoglobin (Mirbehbahani, N.B., et al, 2013). 
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1.2.4 Molecular basis of α-thalassaemia 
 
 
1.2.4.1 Alpha Globin Gene Cluster 
 
The genes that regulate the synthesis and structures of the different globins 
are organised in two separate clusters. The α-globin gene cluster is located 
on chromosome 16 at position 16p13.3 and mutations or deletions affecting 
either one or more α-globin genes results in α-thalassaemia syndrome. In 
contrast, the β-globin gene cluster is located on chromosome 11. The α-
globin gene cluster contains one embryonic ζ- and two α-globin gene 
designated α1 and α2 arranged in the order of 5’- ζ2-α2-α1-3’ on each 
chromosome 16 (Plate 1.1). There are four pseudogenes: ψζ1, ψα2, ψα1 
and ψϴ1 within the α -globin gene cluster (Forget, B.G., 2001). Since 
individual has two chromosomes 16, there are usually a total of four 
functional α-globin genes. But the number can vary from none to as many as 
eight α-globin genes due to misaligned recombination (David, H.K. Chui, 
2005).  
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Plate 1.1: Schematic representation of the α-globin gene cluster and β-globin 
gene cluster. The β-LCR and HS40 is the main regulatory region for these 
gene clusters. (According to Weatherall & Clegg, 2001) 
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1.2.5 α-Thalassaemia 
 
α-thalassaemia is classified into deletional and non-deletional types (Bain BJ, 
2006). There are at least 40 different deletions in deletional mutation and the 
size of the deletion is important and affects the clinical phenotype of hydrops 
foetalis. In contrast, non-deletional mutations may have a more severe 
phenotype than most of the deletional mutations. The most common non-
deletional α-thalassaemia mutation is Haemoglobin Constant Spring 
(Vichinsky, E.P., 2009). 
 
α-thalassaemia is mainly caused by a large deletion of the α-globin gene 
(Choopayak, C et al., 2005). The α-thalassaemia is a haemolytic anaemia 
resulting from deficient synthesis of α-globin. Normal individuals have four α-
globin genes. α-thalassaemia can results from deletion of either one, two, 
three or four α-globin genes (Wee, Y.C et al., 2005). α-thalassaemia also can 
cause the progressive decrease in α-globin chain synthesis in carrier of  α-
thalassaemia, haemoglobin H disease and Haemoglobin Bart’s hydrop 
foetalis syndrome (Winichagoon, P et al, 1984).  
 
There are two major types of α-thalassaemia determinants which α° and α+. 
α°-thalassaemia or formerly called as α-thalassaemia-1 represent a condition 
in which both α-globin genes on chromosome are inactivated. In contrast,   
α+-thalassaemia also called as α-thalassaemia-2 represent a condition in 
which one of the two linked α-globin genes on a chromosome is inactivate 
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and can be caused either by deletion or mutation ( Neishabury, M et al, 
2001). 
 
1.2.5.1 Common α-thalassaemia deletions 
 
(a) α°-thalassaemia or α-thalassaemia-1  
 
α°-thalassaemia deletion determinant caused by complete or partial deletion 
of both genes in cis. Generally there are about 20 α°-thalassaemia deletions 
that tend to be recurrent in various populations. The prevalence of               
α°-thalassaemia in Columbia is 3-6% with --SEA/αα genotype (Bergstrome 
Jones, A.K., and Poon, A., 2002). In pregnant Lao women, 8.7% of SEA 
deletion were detected (Savongsi, O., 2008). In Malaysia itself from the data 
by Institute for Medical Research showed 17.6% of having --SEA deletion. 
(Rahimah, A et al, 2013) 
 
In South East Asia population, the most common α°-thalassaemia is the 
Southeast Asian (--SEA) deletion, Filipino (--FIL) and the Thai (--THAI) deletion, 
respectively (Wee, Y.C et al 2005; Nattaya, Sae-Ung, 2007; Chiara, D.B et 
al, 2006). While, the Mediterranean (--MED) and 20.5 kb deletion (--20.5) was 
commonly found in Mediterranean populations. These deletions remove both 
functional α-globin genes but spare the ζ2-globin gene intact (Nicholls, R.D 
et al, 1987). The α°-thalassaemia is the complete loss of both functional α-
globin genes in tandem on the same chromosome mainly caused by deletion 
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and the deletions presented with mild hypochromic microcytic anaemia 
(Rahimah, A et al, 2012). 
 
In α°-thalassaemia, there is a deletion that removes about 17.5kb of DNA. 
This includes the α1 and α2 genes from the α-globin gene cluster. The 5’ 
breakpoint may start within the third exon of the ¥£ gene and the 3’ end may 
terminate within the hypervariable region which was located at the 3’ end of 
the α-globin gene complex (Fuchareon, S., & Winichagoon. P., 2002). 
 
(b) α+-thalassaemia or α-thalassaemia-2 
 
Deletion of either one of the linked pairs of α-globin gene is classified as    
α+-thalassaemia. α+-thalassaemia is the most common α-thalassaemia 
mutation. There are two common deletion forms of α+-thalassaemia that are 
designated by the size of the deletion as -α3.7 and -α4.2. The most common 
form is the rightward -α3.7 deletion which involving a deletion of 3.7kb of DNA 
between the duplicate α-gene, while the less common deletion involving a 
deletion of 4.2kb of DNA including the α2 gene deletion are the leftward -α4.2 
deletion. Both of these deletions result from unequal homologous 
recombination within the α-globin cluster (Fuchareon, S., & Winichagoon, P., 
2002).  
 
Each α-globin gene is located within a homologous area of 4 kb length 
including two non-homologous sections. These two globin genes are 
imbedded in a large region of homology which is dividing by subsequent 
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insertions and deletions to give three homology sub segments on each α-
globin gene. These homology sub segments are called X, Y and Z boxes. 
Duplicated or the crossover can occur between the two X regions separated 
by 4.2kb or the two Z regions which separated by 3.7kb apart (Neishabury, M 
et al, 2001).  
 
There are over 20 million carrier of α+-thalassaemia in the world, with the 
highest incidence found in the population of India, Southeast Asian and 
Africa and less commonly in the Mediterranean and Middle East. The -α3.7 
deletion is the extremely wide spread. The frequency of the -α3.7 mutation 
can reach very high level. In Malaysia, the prevalence of the heterozygous 
state of -α3.7 is approximately 5-10% and -α4.2 were 0.06% (Wee, Y.C et al, 
2005), in the Mediterranean region, 43% of Jordanian thalassemic 
represents the -α3.7 deletion (Abu Ghoush, 2008). While the -α4.2 is frequently 
found in Asia as in Malaysia, in the previous study done by Wee, Y.C, 0.06% 
of -α4.2 deletion was detected among randomly selected 650 pregnant 
women in University Malaya Medical Centre (UMMC). 
 
 
 
 
 
 
 
17 
 
1.2.5.2 Clinical Syndromes of α - thalassaemia 
 
The clinical syndromes of α-thalassaemia can be subdivided into four 
categories which are α-thalassaemia trait, silent carrier, Hb H disease, and 
Haemoglobin Bart’s hydrops foetalis syndrome. 
 
• Silent Carrier (loss of one α globin gene). The haematological 
parameters are within normal limit. 
• α-thalassaemia trait (loss of two α globin gene). There a mild 
haematological changes with normal or borderline low Hb level, low 
MCV but no major clinical abnormality. 
• Hb H disease (loss of three α globin gene). The clinical severity is 
considerable variability. 
• Haemoglobin Bart’s hydrops foetalis syndrome (no functional α-gene). 
Loss of all four α globin gene showed severe anaemia and hypoxia in 
utero, incompatible with life, resulting in mid- to late-gestational 
stillbirth of hydropic foetus. 
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(a) Silent carrier: Loss of a single α-globin gene  
 
Retention of the three normal α-globin gene results in a silent carrier state 
and the -α3.7 deletion is the most common single gene disorder worldwide. 
The hematologic parameters of the individuals who have a single α-globin 
gene almost always normal and they are clinically well with no RBC 
alterations (Rappaport, V.J., 2004) (Table 1.2). 
 
(b) α-thalassaemia trait : Loss of a two α-globin gene 
 
The α-thalassaemia trait can be caused by heterozygous α-thalassaemia-1 (-
-/αα) or homozygous α-thalassaemia-2 (-α/-α). The most frequent cause of α-
thalassaemia trait is homozygosity for the -α3.7 deletion (-α3.7/-α3.7). While the 
less frequent --/αα genotype can also underlie this phenotype, most 
commonly in Southeast Asian populations. This genotype is usually 
associated with a significant microcytosis and hypochromia, an elevated red 
cell count but normal or borderline low haemoglobin level. The haemoglobin 
electrophoresis is normal however MCV is decreased. (John, S.W., & David, 
H.K.C, 2001) (Table 1.2).   
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(c) Hb H disease  
 
Haemoglobin H disease is an inherited haemoglobin disorder in which three 
of the four α globin gene are deleted or have mutation. There is a marked 
excess of β-globin chains, which are unstable, precipitate within the cell and 
lead to destruction of the red blood cells. Hb H disease is the most severe of 
the α-thalassaemia phenotypes compatible with life. It most frequently results 
from the interaction of α-thalassaemia-1 and α-thalassaemia-2 and it is 
commonly found in Southeast Asia and Mediterranean. Beside that Hb H 
disease may also result from the interaction of nondeletion mutations (Vefik, 
A., & Secil, G.A, 2012).  
 
The clinical picture of Hb H disease is that of a chronic haemolytic anaemia 
of variable severity. Individuals with Hb H disease have moderate to severe 
anaemia but seldom requires transfusions except possibly during infection 
and during pregnancy. The degree of anaemia in Hb H patients with deletion 
of two α globin gene plus nondeletional α2 globin gene mutation is more 
severe than those with deletion of three α globin gene and in some rare 
cases Hb H disease can lead to hydrops foetalis with intrauterine demise. 
(John, S.W., & David, H.K.C, 2001).    
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(d) Hb Bart’s Hydrop Foetalis 
 
Hb Bart’s hydrop foetalis or homozygous α0-thalassaemia is the most severe 
form of α-thalassaemia, resulting from a complex lack of α-chain production, 
which always deletional in origin. If both parents are carrier of                     
α0-thalassaemia with deletion of both α-globin genes in cis, there is a 25% 
risk in each pregnancy that the foetus might have inherited both parental 
mutations. The affected foetus have inherited deletion completely remove the 
entire four α-globin gene. Many of these foetuses survive to the second or 
even third trimester of gestation or death within hours after death. These 
embryos also suffer from severe anaemia and hypoxia in utero.  Apart from 
foetal death, Hb Bart’s hydrop foetalis is also have risk of severe maternal 
complications that include pre-eclampsia, hypertension, toxaemia, 
antepartum haemorrhage, premature onset of labour and postpartum 
haemorrhage (Wee, Y.C et al, 2005) .  
 
 
 
 
 
 
 
 
 
 
 
 
21 
 
Table 1.2 : α-thalassaemia syndromes ( Adapted from Waye and Chui, 2001) 
 
Clinical 
Syndrome 
α-globin 
genotype 
Clinical and 
laboratory 
findings 
Reproductive 
significance* 
Normal αα/αα Clinically Well None 
    
α-
thalassaemia-
silent carrier 
-α/αα  
αThα/αα or 
ααTh/αα 
Normal Hb level. 
Normal or 
borderline low 
MCV. Clinically 
well. 
Hb H disease 
    
α-
thalassemia 
trait 
-α/-α  
αThα/-α or ααTh/-α 
 
 
 
--/αα  
Normal or 
borderline low Hb 
level. Low 
MCV.Clinically well 
 
Normal or 
borderline low Hb 
level. Low 
MCV.Clinically well 
Hb H disease 
 
 
 
Hb H disease. 
Hb  
Bart’s hydrops 
foetalis 
    
Hb H disease -α/--  
αThα/-- or ααTh/-- 
 
Moderate anaemia. 
Low MCV. Usually 
not transfusion 
dependent. 
Hb H disease. 
Hb  
Bart’s hydrops 
foetalis 
    
Hb  
Bart’s 
hydrops 
foetalis 
--/--  
 
Severe anaemia 
and hypoxia in 
utero. Foetal death 
in 2nd and 3rd 
trimester or death 
within hours after 
death. Risk of 
severe maternal 
complications. 
Not 
applicable. 
*Potential risk of foetus inherited with these α-thalassaemia syndromes, depending 
on partner’s α-globin genotype. 
Hb=haemoglobin, αTh=non deletional α-thalassaemia mutation involving either α2- 
or α1-globin gene, MCV=mean corpuscular volume. 
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1.2.6 Carrier screening of α-thalassaemia 
 
1.2.6.1 Peripheral Blood Film 
 
 
The first essential test that need to be performed was full blood cell count 
(FBC) looking for anaemia, microcytosis and hypochromia. The most 
important diagnostic criteria to detect thalassaemia carrier are microcytosis 
or hypochromia. Microcytosis refer to mean corpuscular volume (MCV) <80fl 
while hypochromia are mean corpuscular haemoglobin (MCH) <27pg 
(Leung, W.C et al, 2008).  It is well known that the patients with                   
α0-thalassaemia are not anaemic but do have microcytosis. Therefore it is 
important physician pay attention not only to the Hb levels, but also the MCV 
and MCH levels (Chui, D.H., & Waye, J.S., 1998).  
 
1.2.6.2 Hb H inclusion test 
 
 
The Hb H inclusion test is used extensively in screening for subject with        
α-thalassaemia. The test based on incubation of erythrocyte with brilliant 
cresyl blue. It is quite laborious to scan for Hb H granules and faulty 
incubation of erythrocyte may give rise to false-positive results. The Hb H 
inclusion body test does not detect α+-thalassaemia but is moderately 
sensitive and highly specific for α0-thalassaemia trait due to the SEA, FIL, 
and MED deletions (Fucharoen, G., 2014). 
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1.2.6.3 Hb Analysis 
 
(a) High Performance Liquid Chromatography (HPLC) 
 
 
 
Haemoglobin (Hb) analysis and quantification of Hb A2 should be performed 
as part of screening methods to diagnose thalassaemia carriers. Carriers of 
α-thalassaemia trait have Hb A2 level <3.5% and for the elevated Hb A2 level 
(>3.5%) the person maybe a carrier of β-thalassaemia (John, S.W., & David, 
H.K.C, 2001). DNA analysis for α-thalassaemia is necessary for diagnosis.  
 
(b) Capillary Electrophoresis 
 
 
Capillarys Electrophoresis (CE) is the recent most advanced technology 
which provides walkway convenience for electrophoresis. This CE approved 
method offers quantitation and detection of normal and abnormal 
haemoglobins, as an aid in the diagnosis of haemoglobinopathies and 
thalassaemias. With this technique, charged Hb molecules are separated by 
their electrophoretic mobilities in alkaline buffer with a speciﬁc pH. 
Separation also occurs according to the electrolyte pH and electro osmotic 
ﬂow created from negative charges on the capillary wall that shorten the 
analysis duration haemoglobinopathy and thalassaemia detection 
(Srivorakun, H., 2011).  
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(c) Gel Electrophoresis 
 
Electrophoresis of haemoglobin on agar at acidic pH has been introduces 
some forty years ago. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
